You just read:

Lexicon Announces FDA Priority Review Of New Drug Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome

News provided by

Lexicon Pharmaceuticals, Inc.

May 31, 2016, 08:00 ET